Showing results (151-160 of 214) with videos related to
Sort By:
Pageof 22
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2016
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 ResultsDavid Wohl, Shinichi Oka, Nathan Clumeck, et al.The Journal of Infectious Diseases|December 16, 2003
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infectionJeffrey M Jacobson, Michael M Lederman, John Spritzler, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2019
Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ARTRoger J Bedimo, Hanna Mar, Ronald J Bosch, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2016
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 InfectionJeffrey M Jacobson, Lu Zheng, Cara C Wilson, et al.Pathogens & Immunity|September 27, 2016
A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Michael M Lederman, Paula M Cannon, Judith S Currier, et al.Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trialChloe Orkin, Rosie Mngqibisa, Juan Diego Velez, et al.Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral TherapyConstance A Benson, Janet W Andersen, Bernard J C Macatangay, et al.Nature Communications|June 30, 2021
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIVLeila B Giron, Clovis S Palmer, Qin Liu, et al.AIDS Research and Human Retroviruses|March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.Pageof 22